Conditions: Axial Spondyloarthritis
Keywords: Etanercept Axial Spondyloarthritis NSAIDs sparing effect
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 90
Healthy volunteers: no

Brief summary:
This study will compare the Non Steroidal Anti-Inflammatory Drugs (NSAIDs) sparing effect of etanercept with that of placebo in adult subjects with axial Spondyloarthritis.

Detailed description:

Arms:
arm 1: Group A: etanercept 50 mg subcutaneous (SC) injections once weekly for 16 weeks. arm 2: Group B: placebo subcutaneous (SC) injections once weekly for (how many) weeks follwed by etanercept 50 mg SC injections once weekly.

Interventions: intervention 1: etanercept intervention 2: etanercept intervention 3: placebo
Intervention descriptions: intervention 1: etanercept 50 mg subcutaneous (SC) injections once weekly for 16 weeks. intervention 2: etanercept 50 mg subcutaneous (SC) injections once weekly for 8 weeks following the prior 8 weeks of placebo. intervention 3: placebo subcutaneous (SC) injections once weekly for 8 weeks.

Protocol document: